Auris Medical Receives FDA and EMA Guidance for Keyzilen® Late-Stage Clinical Development Program

NEXT STORY
National Patient Survey Highlights Healthcare Challenges for the 1 in 4 Americans Living with Rheumatic Disease
PREV STORY
Novartis Phase III ASCLEPIOS trials demonstrate robust efficacy of ofatumumab in patients with relapsing multiple sclerosis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Radius Health Reports First Quarter 2017 Financial and Operating Results

US FDA approves TYMLOS™ (abaloparatide) on April 28, 2017, first new bone builder in ...

author_avatar
NASDAQ Market News

Data from Prospective Phase 2 Study Investigating Delcath’s PHP Therapy presented at CIRSE 2018

Positive Results Observed in Study Endpoints Comparable to Endpoints in Delcath Registration TrialNEW YORK, ...

author_avatar
NASDAQ Market News

Beyond Celiac hiring Chief Scientific Officer Marie Robert, MD

Philadelphia, PA, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Beyond Celiac has announced the hiring ...

author_avatar
NASDAQ Market News